

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.73640245 |
| 2 | cytidine metabolic process (GO:0046087) | 6.90111508 |
| 3 | cytidine catabolic process (GO:0006216) | 6.90111508 |
| 4 | cytidine deamination (GO:0009972) | 6.90111508 |
| 5 | diterpenoid biosynthetic process (GO:0016102) | 6.04672581 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.52540660 |
| 7 | DNA deamination (GO:0045006) | 4.77078189 |
| 8 | terpenoid biosynthetic process (GO:0016114) | 4.67795527 |
| 9 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.67268469 |
| 10 | eosinophil chemotaxis (GO:0048245) | 4.39748661 |
| 11 | membrane raft organization (GO:0031579) | 4.13710444 |
| 12 | negative regulation of protein localization to cell surface (GO:2000009) | 3.99651477 |
| 13 | ER overload response (GO:0006983) | 3.99340461 |
| 14 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.91839558 |
| 15 | eosinophil migration (GO:0072677) | 3.86497103 |
| 16 | inositol phosphate-mediated signaling (GO:0048016) | 3.74384189 |
| 17 | regulation of transmission of nerve impulse (GO:0051969) | 3.62831588 |
| 18 | response to peptidoglycan (GO:0032494) | 3.52145783 |
| 19 | retinal metabolic process (GO:0042574) | 3.49792861 |
| 20 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.44815369 |
| 21 | hemidesmosome assembly (GO:0031581) | 3.40329616 |
| 22 | xenobiotic catabolic process (GO:0042178) | 3.39300715 |
| 23 | mitotic cytokinesis (GO:0000281) | 3.37544024 |
| 24 | branch elongation of an epithelium (GO:0060602) | 3.36002780 |
| 25 | protein targeting to vacuole (GO:0006623) | 3.31898911 |
| 26 | protein targeting to lysosome (GO:0006622) | 3.31898911 |
| 27 | establishment of protein localization to vacuole (GO:0072666) | 3.31898911 |
| 28 | energy homeostasis (GO:0097009) | 3.30384273 |
| 29 | monocyte chemotaxis (GO:0002548) | 3.30241685 |
| 30 | positive regulation of type 2 immune response (GO:0002830) | 3.27974044 |
| 31 | positive regulation of bone remodeling (GO:0046852) | 3.23682118 |
| 32 | positive regulation of bone resorption (GO:0045780) | 3.23682118 |
| 33 | negative regulation of macroautophagy (GO:0016242) | 3.21264490 |
| 34 | ganglioside metabolic process (GO:0001573) | 3.19730414 |
| 35 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.17432997 |
| 36 | artery smooth muscle contraction (GO:0014824) | 3.13440621 |
| 37 | cytoskeleton-dependent cytokinesis (GO:0061640) | 3.09838165 |
| 38 | response to lipoprotein particle (GO:0055094) | 3.08904713 |
| 39 | positive regulation of p38MAPK cascade (GO:1900745) | 3.08792902 |
| 40 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.07366066 |
| 41 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.07366066 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06201000 |
| 43 | protein localization to lysosome (GO:0061462) | 3.06069506 |
| 44 | protein localization to vacuole (GO:0072665) | 3.06069506 |
| 45 | decidualization (GO:0046697) | 3.02646556 |
| 46 | actin nucleation (GO:0045010) | 3.02280832 |
| 47 | centriole replication (GO:0007099) | 2.99987712 |
| 48 | Golgi to plasma membrane protein transport (GO:0043001) | 2.98279783 |
| 49 | T cell lineage commitment (GO:0002360) | 2.96287875 |
| 50 | regulation of axon regeneration (GO:0048679) | 2.94197347 |
| 51 | regulation of neuron projection regeneration (GO:0070570) | 2.94197347 |
| 52 | positive regulation of heat generation (GO:0031652) | 2.93968608 |
| 53 | response to caffeine (GO:0031000) | 2.93172327 |
| 54 | cellular response to ATP (GO:0071318) | 2.91519966 |
| 55 | regulation of collateral sprouting (GO:0048670) | 2.90504979 |
| 56 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.87024305 |
| 57 | positive regulation of tissue remodeling (GO:0034105) | 2.83106121 |
| 58 | cullin deneddylation (GO:0010388) | 2.82156893 |
| 59 | intestinal epithelial cell development (GO:0060576) | 2.79117672 |
| 60 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.77115649 |
| 61 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.76958230 |
| 62 | response to xenobiotic stimulus (GO:0009410) | 2.75935660 |
| 63 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.75484202 |
| 64 | regulation of mononuclear cell migration (GO:0071675) | 2.75130424 |
| 65 | metaphase plate congression (GO:0051310) | 2.74228267 |
| 66 | tonic smooth muscle contraction (GO:0014820) | 2.72240069 |
| 67 | positive regulation of prostaglandin secretion (GO:0032308) | 2.72203301 |
| 68 | negative regulation of viral genome replication (GO:0045071) | 2.71674377 |
| 69 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.71597361 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 2.71284001 |
| 71 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.71258730 |
| 72 | production of molecular mediator of immune response (GO:0002440) | 2.71232497 |
| 73 | proteasome assembly (GO:0043248) | 2.70811054 |
| 74 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.68226469 |
| 75 | negative regulation of complement activation (GO:0045916) | 2.65966808 |
| 76 | neutrophil mediated immunity (GO:0002446) | 2.65839141 |
| 77 | natural killer cell activation involved in immune response (GO:0002323) | 2.65557348 |
| 78 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.65100621 |
| 79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.63406329 |
| 80 | regulation of defense response to virus by host (GO:0050691) | 2.62753015 |
| 81 | response to vitamin D (GO:0033280) | 2.62284090 |
| 82 | regulation of fever generation (GO:0031620) | 2.61473742 |
| 83 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.60946553 |
| 84 | negative regulation of gluconeogenesis (GO:0045721) | 2.60872245 |
| 85 | response to pheromone (GO:0019236) | 2.60677865 |
| 86 | fibroblast migration (GO:0010761) | 2.60500900 |
| 87 | kynurenine metabolic process (GO:0070189) | 2.59971100 |
| 88 | protein targeting to Golgi (GO:0000042) | 2.58399389 |
| 89 | negative regulation of acute inflammatory response (GO:0002674) | 2.58002171 |
| 90 | positive regulation of acute inflammatory response (GO:0002675) | 2.57872080 |
| 91 | positive regulation of defense response to virus by host (GO:0002230) | 2.57853239 |
| 92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.57067570 |
| 93 | spindle assembly involved in mitosis (GO:0090307) | 2.57037981 |
| 94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.55678813 |
| 95 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53684770 |
| 96 | establishment of protein localization to Golgi (GO:0072600) | 2.51974849 |
| 97 | positive regulation of calcium ion import (GO:0090280) | 2.51671355 |
| 98 | regulation of interferon-alpha production (GO:0032647) | 2.49924860 |
| 99 | negative regulation of cytokine biosynthetic process (GO:0042036) | 2.49423942 |
| 100 | establishment of chromosome localization (GO:0051303) | 2.48515206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.61508019 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.17093743 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.90593914 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.90565389 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.87019963 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.76512855 |
| 7 | TP53_16413492_ChIP-PET_HCT116_Human | 2.73925532 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.65259678 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.51181642 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.36386169 |
| 11 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.27773768 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.09572179 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08938107 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03335461 |
| 15 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.00860559 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99968497 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87551823 |
| 18 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.86816631 |
| 19 | CJUN_26792858_Chip-Seq_BT549_Human | 1.82523434 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.78490115 |
| 21 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.77560680 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77358449 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74997716 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67547305 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64329102 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63820640 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62552498 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62238847 |
| 29 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.61919357 |
| 30 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60867003 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60853754 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60682889 |
| 33 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.59483981 |
| 34 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.56429006 |
| 35 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.56429006 |
| 36 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.56256482 |
| 37 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54488028 |
| 38 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.53910468 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.52540833 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.50452208 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50413938 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49989140 |
| 43 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48873656 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48622355 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47881225 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45605468 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44110886 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42324398 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42324398 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41393686 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40370207 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37171687 |
| 53 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.33015237 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31602380 |
| 55 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.30759549 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30389569 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30357636 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30357636 |
| 59 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.27733440 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26994471 |
| 61 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26984056 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26231041 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26093368 |
| 64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25421434 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25069093 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21665823 |
| 67 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21508241 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20652277 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19004647 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18791325 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18451875 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18117456 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17170751 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16738494 |
| 75 | NFYB_21822215_ChIP-Seq_K562_Human | 1.16027410 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13992932 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13201633 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10435812 |
| 79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08063752 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07730729 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07158756 |
| 82 | TBL1_22424771_ChIP-Seq_293T_Human | 1.07086617 |
| 83 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06815436 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06146709 |
| 85 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.04584659 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03054893 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02790389 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.01559855 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00012749 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99693333 |
| 91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98064281 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97606284 |
| 93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.97428264 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97388381 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97356154 |
| 96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97356154 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96151894 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95733823 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94883640 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94810161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 8.53798742 |
| 2 | MP0006082_CNS_inflammation | 6.79950546 |
| 3 | MP0003950_abnormal_plasma_membrane | 4.02331444 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.36669162 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.29915759 |
| 6 | MP0004272_abnormal_basement_membrane | 2.99353642 |
| 7 | MP0009840_abnormal_foam_cell | 2.71156990 |
| 8 | MP0002332_abnormal_exercise_endurance | 2.60345781 |
| 9 | MP0009785_altered_susceptibility_to | 2.43096949 |
| 10 | MP0005408_hypopigmentation | 2.09155156 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.03533260 |
| 12 | MP0002163_abnormal_gland_morphology | 2.00615163 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 1.99414544 |
| 14 | MP0005360_urolithiasis | 1.97236267 |
| 15 | MP0000920_abnormal_myelination | 1.80626943 |
| 16 | MP0002102_abnormal_ear_morphology | 1.77351510 |
| 17 | MP0003283_abnormal_digestive_organ | 1.77310301 |
| 18 | MP0009278_abnormal_bone_marrow | 1.74363746 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.73637507 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 1.72590333 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 1.66061886 |
| 22 | MP0002254_reproductive_system_inflammat | 1.55209897 |
| 23 | MP0003252_abnormal_bile_duct | 1.53045762 |
| 24 | MP0010678_abnormal_skin_adnexa | 1.49640941 |
| 25 | MP0005164_abnormal_response_to | 1.49305199 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.46780673 |
| 27 | MP0005023_abnormal_wound_healing | 1.45668283 |
| 28 | MP0005310_abnormal_salivary_gland | 1.42941441 |
| 29 | MP0000749_muscle_degeneration | 1.37310970 |
| 30 | MP0005387_immune_system_phenotype | 1.31966720 |
| 31 | MP0001790_abnormal_immune_system | 1.31966720 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.30620076 |
| 33 | MP0000383_abnormal_hair_follicle | 1.26732706 |
| 34 | MP0003690_abnormal_glial_cell | 1.26176539 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.24170590 |
| 36 | MP0005266_abnormal_metabolism | 1.23777800 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.20126612 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.20126612 |
| 39 | MP0003091_abnormal_cell_migration | 1.20093934 |
| 40 | MP0005165_increased_susceptibility_to | 1.13231943 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.10227308 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.09883763 |
| 43 | MP0005671_abnormal_response_to | 1.06826668 |
| 44 | MP0004883_abnormal_blood_vessel | 1.02728999 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.02687826 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.00402119 |
| 47 | MP0002168_other_aberrant_phenotype | 1.00337767 |
| 48 | MP0002269_muscular_atrophy | 0.97307337 |
| 49 | MP0000343_altered_response_to | 0.96566250 |
| 50 | MP0001873_stomach_inflammation | 0.96529777 |
| 51 | MP0000371_diluted_coat_color | 0.96292769 |
| 52 | MP0003045_fibrosis | 0.96082697 |
| 53 | MP0005332_abnormal_amino_acid | 0.95071441 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94536604 |
| 55 | MP0003136_yellow_coat_color | 0.94114160 |
| 56 | MP0002006_tumorigenesis | 0.93956114 |
| 57 | MP0004947_skin_inflammation | 0.93537845 |
| 58 | MP0006054_spinal_hemorrhage | 0.92856430 |
| 59 | MP0001191_abnormal_skin_condition | 0.91813010 |
| 60 | MP0009053_abnormal_anal_canal | 0.89434495 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 0.86314834 |
| 62 | MP0001835_abnormal_antigen_presentation | 0.85217050 |
| 63 | MP0005376_homeostasis/metabolism_phenot | 0.85172041 |
| 64 | MP0002734_abnormal_mechanical_nocicepti | 0.81231869 |
| 65 | MP0002095_abnormal_skin_pigmentation | 0.80866092 |
| 66 | MP0001845_abnormal_inflammatory_respons | 0.80565725 |
| 67 | MP0001800_abnormal_humoral_immune | 0.78375650 |
| 68 | MP0003724_increased_susceptibility_to | 0.78313197 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 0.78292507 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.76301027 |
| 71 | MP0002452_abnormal_antigen_presenting | 0.76178281 |
| 72 | MP0002166_altered_tumor_susceptibility | 0.75923971 |
| 73 | MP0002693_abnormal_pancreas_physiology | 0.75853506 |
| 74 | MP0002723_abnormal_immune_serum | 0.75811040 |
| 75 | MP0001243_abnormal_dermal_layer | 0.73932264 |
| 76 | MP0005595_abnormal_vascular_smooth | 0.73413144 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.73234116 |
| 78 | MP0000685_abnormal_immune_system | 0.72215005 |
| 79 | MP0002419_abnormal_innate_immunity | 0.69616507 |
| 80 | MP0002796_impaired_skin_barrier | 0.69062871 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.67291325 |
| 82 | MP0001529_abnormal_vocalization | 0.66238956 |
| 83 | MP0005166_decreased_susceptibility_to | 0.65875399 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.65222845 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.65208556 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.64647449 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 0.63457241 |
| 88 | MP0001764_abnormal_homeostasis | 0.63251092 |
| 89 | MP0005647_abnormal_sex_gland | 0.62068562 |
| 90 | MP0005025_abnormal_response_to | 0.58358827 |
| 91 | MP0001905_abnormal_dopamine_level | 0.57999604 |
| 92 | MP0008469_abnormal_protein_level | 0.57782009 |
| 93 | MP0009764_decreased_sensitivity_to | 0.57064719 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.56974045 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.56914508 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.56874470 |
| 97 | MP0003303_peritoneal_inflammation | 0.56732217 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.56186829 |
| 99 | MP0003633_abnormal_nervous_system | 0.55391849 |
| 100 | MP0009763_increased_sensitivity_to | 0.54988326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperkalemia (HP:0002153) | 5.57432672 |
| 2 | Urethral obstruction (HP:0000796) | 5.47976515 |
| 3 | Stenosis of the external auditory canal (HP:0000402) | 5.44626479 |
| 4 | Thick nail (HP:0001805) | 4.17243551 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 3.92488781 |
| 6 | Increased IgM level (HP:0003496) | 3.79421584 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 3.57747577 |
| 8 | Milia (HP:0001056) | 3.51110083 |
| 9 | Alopecia of scalp (HP:0002293) | 3.39169815 |
| 10 | Posterior subcapsular cataract (HP:0007787) | 3.36361046 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.30875868 |
| 12 | Pancreatic cysts (HP:0001737) | 3.29919007 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26723065 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26723065 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26723065 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.23555519 |
| 17 | Mitral stenosis (HP:0001718) | 3.21940079 |
| 18 | Vascular calcification (HP:0004934) | 3.20819007 |
| 19 | Lip pit (HP:0100267) | 3.12437224 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.05185117 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.05185117 |
| 22 | Type I transferrin isoform profile (HP:0003642) | 3.05126564 |
| 23 | Prolonged neonatal jaundice (HP:0006579) | 3.04233567 |
| 24 | Hyponatremia (HP:0002902) | 3.03667220 |
| 25 | Atonic seizures (HP:0010819) | 3.02452567 |
| 26 | Abnormality of T cell number (HP:0011839) | 2.92034842 |
| 27 | Cardiovascular calcification (HP:0011915) | 2.81659383 |
| 28 | Termporal pattern (HP:0011008) | 2.74038290 |
| 29 | Insidious onset (HP:0003587) | 2.74038290 |
| 30 | Prostate neoplasm (HP:0100787) | 2.73875021 |
| 31 | Exercise-induced muscle cramps (HP:0003710) | 2.62168677 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.50858527 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.50858527 |
| 34 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.50858527 |
| 35 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.50858527 |
| 36 | Glossoptosis (HP:0000162) | 2.48556465 |
| 37 | Azoospermia (HP:0000027) | 2.47682443 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.44112490 |
| 39 | Abnormality of renal excretion (HP:0011036) | 2.44044068 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.42131297 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.41932445 |
| 42 | Exocrine pancreatic insufficiency (HP:0001738) | 2.39830061 |
| 43 | Potter facies (HP:0002009) | 2.37398349 |
| 44 | Facial shape deformation (HP:0011334) | 2.37398349 |
| 45 | Hyperventilation (HP:0002883) | 2.35778211 |
| 46 | Bifid tongue (HP:0010297) | 2.32316473 |
| 47 | Tubular atrophy (HP:0000092) | 2.30879246 |
| 48 | Loss of speech (HP:0002371) | 2.27061514 |
| 49 | Intrahepatic cholestasis (HP:0001406) | 2.24433110 |
| 50 | Scanning speech (HP:0002168) | 2.23846984 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.23781168 |
| 52 | Aplastic anemia (HP:0001915) | 2.23565612 |
| 53 | Volvulus (HP:0002580) | 2.23471029 |
| 54 | Abnormal auditory evoked potentials (HP:0006958) | 2.23088295 |
| 55 | Pheochromocytoma (HP:0002666) | 2.18209151 |
| 56 | Hypokinesia (HP:0002375) | 2.13876931 |
| 57 | Median cleft lip (HP:0000161) | 2.10523567 |
| 58 | Abnormality of sodium homeostasis (HP:0010931) | 2.10089930 |
| 59 | Parakeratosis (HP:0001036) | 2.06969166 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.04565519 |
| 61 | Abnormality of potassium homeostasis (HP:0011042) | 2.02729315 |
| 62 | Late onset (HP:0003584) | 2.00759303 |
| 63 | Polydipsia (HP:0001959) | 1.99361320 |
| 64 | Abnormal drinking behavior (HP:0030082) | 1.99361320 |
| 65 | Horizontal nystagmus (HP:0000666) | 1.99219776 |
| 66 | Abnormal urine output (HP:0012590) | 1.99190753 |
| 67 | Febrile seizures (HP:0002373) | 1.98589325 |
| 68 | Tetraparesis (HP:0002273) | 1.97238347 |
| 69 | Hypothermia (HP:0002045) | 1.96547623 |
| 70 | Microretrognathia (HP:0000308) | 1.96147603 |
| 71 | Absent speech (HP:0001344) | 1.95994038 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 1.95716254 |
| 73 | Glycosuria (HP:0003076) | 1.95382021 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 1.95382021 |
| 75 | Neonatal respiratory distress (HP:0002643) | 1.93142219 |
| 76 | Joint swelling (HP:0001386) | 1.92520181 |
| 77 | Choroideremia (HP:0001139) | 1.92229984 |
| 78 | J-shaped sella turcica (HP:0002680) | 1.90465587 |
| 79 | Increased CSF protein (HP:0002922) | 1.89208434 |
| 80 | Hypoplasia of dental enamel (HP:0006297) | 1.89026852 |
| 81 | Eosinophilia (HP:0001880) | 1.86367362 |
| 82 | Tubulointerstitial fibrosis (HP:0005576) | 1.84190040 |
| 83 | Fatigable weakness (HP:0003473) | 1.83499545 |
| 84 | Abnormality of the neuromuscular junction (HP:0003398) | 1.83499545 |
| 85 | Short chin (HP:0000331) | 1.82438184 |
| 86 | Pancreatic fibrosis (HP:0100732) | 1.81864921 |
| 87 | Zonular cataract (HP:0010920) | 1.81297934 |
| 88 | Bradycardia (HP:0001662) | 1.80401939 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 1.80249159 |
| 90 | Cystic liver disease (HP:0006706) | 1.77923700 |
| 91 | Subcapsular cataract (HP:0000523) | 1.76541644 |
| 92 | Petechiae (HP:0000967) | 1.74312916 |
| 93 | Hyperglycemia (HP:0003074) | 1.73686820 |
| 94 | Hydroxyprolinuria (HP:0003080) | 1.71890302 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 1.71890302 |
| 96 | T lymphocytopenia (HP:0005403) | 1.71684215 |
| 97 | Microvesicular hepatic steatosis (HP:0001414) | 1.70270570 |
| 98 | Abnormality of renal resorption (HP:0011038) | 1.69852047 |
| 99 | Progressive neurologic deterioration (HP:0002344) | 1.68283307 |
| 100 | Steatorrhea (HP:0002570) | 1.68128405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.92048797 |
| 2 | MAP3K12 | 4.67684058 |
| 3 | MST4 | 3.53504802 |
| 4 | MST1R | 3.17561636 |
| 5 | BCR | 3.04167256 |
| 6 | TNIK | 3.03736970 |
| 7 | BMPR2 | 2.80523692 |
| 8 | EIF2AK3 | 2.58163907 |
| 9 | ZAK | 2.54554994 |
| 10 | PDK2 | 2.43951956 |
| 11 | IRAK3 | 2.43057815 |
| 12 | CDK8 | 2.24982693 |
| 13 | SCYL2 | 2.23402495 |
| 14 | PLK2 | 2.14742353 |
| 15 | MYLK | 2.14465040 |
| 16 | PIK3CG | 1.99722316 |
| 17 | BRD4 | 1.97375182 |
| 18 | BMPR1B | 1.90488357 |
| 19 | TLK1 | 1.86367411 |
| 20 | MAP4K2 | 1.86276380 |
| 21 | ERBB3 | 1.72240117 |
| 22 | FRK | 1.52350877 |
| 23 | ACVR1B | 1.38893830 |
| 24 | DAPK3 | 1.35699081 |
| 25 | STK38L | 1.33112988 |
| 26 | MAP3K4 | 1.28818274 |
| 27 | VRK1 | 1.23141350 |
| 28 | MET | 1.14542428 |
| 29 | EIF2AK1 | 1.14331401 |
| 30 | ABL2 | 1.11792099 |
| 31 | VRK2 | 1.11490411 |
| 32 | IRAK2 | 1.10525815 |
| 33 | ADRBK2 | 1.08828360 |
| 34 | ERBB4 | 1.03004916 |
| 35 | EPHA2 | 0.99882202 |
| 36 | DAPK1 | 0.99402254 |
| 37 | TRPM7 | 0.99305151 |
| 38 | PAK4 | 0.94038416 |
| 39 | KDR | 0.91096925 |
| 40 | PBK | 0.87065567 |
| 41 | NEK9 | 0.84764245 |
| 42 | GRK1 | 0.83938940 |
| 43 | NEK1 | 0.83799412 |
| 44 | CLK1 | 0.82405648 |
| 45 | PDGFRB | 0.80190559 |
| 46 | TAF1 | 0.77652013 |
| 47 | MAP3K2 | 0.74134304 |
| 48 | ROCK1 | 0.73706508 |
| 49 | BRSK2 | 0.71890300 |
| 50 | MAP3K14 | 0.69574126 |
| 51 | GRK7 | 0.69497056 |
| 52 | PLK3 | 0.68612015 |
| 53 | IRAK4 | 0.68226639 |
| 54 | LATS2 | 0.66793349 |
| 55 | FER | 0.66692465 |
| 56 | IKBKB | 0.66097372 |
| 57 | NEK2 | 0.62593957 |
| 58 | MAP3K3 | 0.62590746 |
| 59 | WEE1 | 0.62456806 |
| 60 | LATS1 | 0.61765858 |
| 61 | PKN1 | 0.59423173 |
| 62 | STK10 | 0.58722077 |
| 63 | TBK1 | 0.57799636 |
| 64 | MELK | 0.57152965 |
| 65 | PRKCE | 0.51206332 |
| 66 | STK39 | 0.50386832 |
| 67 | MAPKAPK5 | 0.49912057 |
| 68 | STK3 | 0.49269676 |
| 69 | NUAK1 | 0.48577051 |
| 70 | ADRBK1 | 0.48460574 |
| 71 | BUB1 | 0.48344224 |
| 72 | CDK9 | 0.47733836 |
| 73 | LIMK1 | 0.47279071 |
| 74 | DAPK2 | 0.45752182 |
| 75 | PNCK | 0.41366116 |
| 76 | AURKA | 0.41131852 |
| 77 | TRIM28 | 0.40777375 |
| 78 | PRKG1 | 0.38355603 |
| 79 | TAOK2 | 0.38087549 |
| 80 | CSNK1G2 | 0.37360723 |
| 81 | PLK1 | 0.37095809 |
| 82 | KSR1 | 0.36973214 |
| 83 | MKNK1 | 0.36421320 |
| 84 | WNK3 | 0.34820369 |
| 85 | MAP2K7 | 0.33805187 |
| 86 | ILK | 0.33071731 |
| 87 | MKNK2 | 0.32245005 |
| 88 | MAP3K6 | 0.31919628 |
| 89 | RPS6KA5 | 0.30249786 |
| 90 | PRKCQ | 0.28639589 |
| 91 | RIPK1 | 0.28435320 |
| 92 | MAP3K5 | 0.27247915 |
| 93 | CAMKK2 | 0.26984300 |
| 94 | PRKCI | 0.26652054 |
| 95 | TESK2 | 0.24739641 |
| 96 | TESK1 | 0.24520625 |
| 97 | PAK3 | 0.23962174 |
| 98 | GSK3A | 0.23345941 |
| 99 | EIF2AK2 | 0.23066503 |
| 100 | CAMK2D | 0.22381504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.55060401 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.89540328 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.75680711 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.57906139 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.37590430 |
| 6 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.34326415 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.28773952 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26589512 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18199422 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.17874416 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.01401866 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97357713 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.89976139 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82735546 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.82476481 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.76558380 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.57629426 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.46554566 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45146649 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44859138 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41355392 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39961810 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37361182 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35640771 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.35314704 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.32680059 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27707567 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27012670 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26219294 |
| 30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24190650 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.24118834 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23266414 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.21152918 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20188266 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16038928 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15870708 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 1.15557538 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15219294 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11331265 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08275262 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06715583 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.05641037 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05434562 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05178760 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05172504 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.04226311 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02450897 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00901991 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.98713674 |
| 50 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96891223 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96838753 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92062919 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89473929 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89266377 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88587502 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86881553 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85525150 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85162559 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82613660 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82398737 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81981453 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81605169 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78052100 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75398362 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75076679 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.69465540 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63870357 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62898204 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61011926 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59406126 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59327373 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58853244 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58331828 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55439932 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54895430 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53812316 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53175194 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51651326 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51393033 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48324884 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.46777571 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46497305 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43415549 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43120513 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42857116 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42794375 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42296913 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40606354 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32590011 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.32274215 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31799856 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30597217 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.30469945 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30110111 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.29915373 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29768844 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27018521 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24703957 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24676016 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23711692 |

